NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

Envista Holdings Corporation (NVST) Stock Analysis

Envista Holdings Corporation (NVST) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

NVST

$27.28

−$0.31 (−1.12%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NVST with… →

NVST Key Statistics

As of Sep 4, 2026
Trading
Open
$27.30
Previous Close
$27.59
Day's Range
27.02–27.51
52-Week Range
18.77–30.42
Volume
1.68M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.86
Valuation
Market Cap
$4.38B
P/E Ratio
47.86
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
16.34
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.53
EPS (ttm)Profit attributable to each share over the last twelve months.
0.57
Financials (FY)
Revenue (FY)
$2.72B+8.32%
Net Income (FY)
$47.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
3.33%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
160.62M
1-Year Return
+31.28%
Dividend and dates
Earnings Date
October 28, 2026estimated
Avg Volume
2.70M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NVST Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+25.66%
2025+12.55%
2024−19.83%
2023−28.54%
2022−25.28%
2021+33.59%
2020+13.80%
2019 (partial year)+6.05%

As of September 4, 2026.

NVST Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.72B$47.00M1.7%
2024$2.51B−$1.12B−44.6%
2023$2.57B−$100.20M−3.9%
2022$2.57B$243.10M9.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.72B$1.49B$235.80M$47.00M1.7%
2024$2.51B$1.37B$137.20M−$1.12B−44.6%
2023$2.57B$1.44B$314.90M−$100.20M−3.9%
2022$2.57B$1.47B$343.20M$243.10M9.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NVST Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricNVSTMedical Instruments & Supplies medianvs median
P/E47.8635.6134% above
P/S ratio1.533.1752% below
Profit margin3.33%0.85%2.5 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Envista Holdings Corporation (NVST) at $4.38B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 12,000 employees.

Over the past 52 weeks the price has ranged from $18.77 to $30.42. The most recent close on file for NVST is $27.28, dated September 4, 2026. That is −$0.31 (−1.12%) against the previous close. The latest close sits 45.34% above that 52-week low.

Financial Health

In fiscal 2025, Envista Holdings Corporation reported revenue of $2.72B. Against the prior fiscal year total of $2.51B, that is a change of +8.32%. Net income for the same year was $47.00M. Profit margin runs at 3.33%. That is 2.5 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 0.57.

Across the 4 fiscal years on file, revenue moves from $2.57B in 2022 to $2.72B in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 47.86. That is 34.38% above the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 16.34. Measured against sales, the shares trade at 1.53 times revenue. On price-to-sales that is 51.65% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

The trailing one-year price return is +31.28%. Measured over 5 years, that is −8.86% a year compounded. The reported beta is 0.86. Daily returns over the trailing 7 years annualize to a volatility of 39.65%.

Growth & Income

No dividend is on file for NVST.

Across the complete calendar years on file, 2021 returned +33.59% and 2023 returned −28.54%. Of the 6 complete calendar years on file, 3 finished higher. So far in 2026 the price is +25.66%.

Peer Comparison

Envista Holdings Corporation (NVST) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Envista Holdings Corporation NVST $4.38B 47.9
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Envista Holdings Corporation trades at a P/E of 47.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Visit website →